Cargando…
CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
The pathogenic mechanisms of these diseases must be well understood for the treatment of neurological disorders such as Huntington's disease. Huntington's Disease (HD), a dominant and neurodegenerative disease, is characterized by the CAG re-expansion that occurs in the gene encoding the p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734918/ https://www.ncbi.nlm.nih.gov/pubmed/36482283 http://dx.doi.org/10.1007/s12035-022-03150-5 |